Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tolvaptan (Atc Code: G04Bx21)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 83625024

  Document Type - Tender Notices

Description - Description: The subject of this publication is the conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the Social Code Book V for medicinal products containing the active ingredient tolvaptan (ATC code: G04BX21). The contract is concluded within the framework of a so-called open house model, i.e. a contract is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. This means that individual contract negotiations are not conducted and there is no (supply) exclusivity. It should be noted that the purchase quantity is unknown, as this depends on demand and the development

Gt Ref Id - 83625024

Deadline - Aug 31, 2026